|
02/17/05 --
Genomes throughout the animal kingdom and beyond are characterized by
extensive segments that are inactive, lengthy stretches of DNA containing
multiple genes that are closed to gene transcription. Scientists believe one
reason for this broad gene silencing is the vital need for genomic
stability, for protection against unwanted recombinations of genetic
material or other disruptions of the genome's integrity.
Genomic instability,
particularly in the regions at the ends of the chromosomes known as
telomeres, has been linked to aging in humans and an elevated risk for
aging-related diseases, the most prominent of which is cancer. For this
reason, insights into the mechanisms of gene silencing could provide
important guideposts for new approaches to retarding aging or treating
cancer.
Now, an investigation led by
researchers at The Wistar Institute has shown that an enzyme known as Ubp10
plays a vital role in protecting the telomeric regions of the genome from
potential destabilizing molecular events. The enzyme helps to keep the
genome structurally closed, unavailable for transcription and possibly
protected from dangerous genetic recombinations with other regions of the
genome. A report on the research, which was conducted in yeast, appears in
the February 18 issue of Molecular Cell.
"There are regions of the
genome that have to be inaccessible," says Shelley L. Berger, Ph.D., the
Hilary Koprowski Professor in the gene expression and regulation program at
Wistar and senior author on the study. "Otherwise, they can recombine with
themselves or with other DNA segments. In the telomeres, such events may
accelerate aging or trigger cancer in humans."
"We have identified a
molecular mechanism to explain how this enzyme helps keep telomeric DNA
silenced and potentially protects the genome from destabilizing activity,"
says N.C. Tolga Emre, a graduate student in Berger's laboratory and lead
author on the study.
The Ubp10 enzyme acts on
histones, molecules that have attracted increasing attention from scientists
as they move beyond sequencing the human genome to trying to better
understand how DNA is managed and its activity regulated. Histones are small
proteins around which DNA is coiled to create structures called nucleosomes.
Compact strings of nucleosomes, then, form into chromatin, the substructure
of chromosomes. In many cases, when the DNA is tightly wrapped around the
histones, the genes cannot be accessed and their expression is repressed.
When the coils of DNA around the histones are loosened or the histone
molecules are altered, the genes become available for expression.
It is the complex activity
governing this process to which Ubp10 contributes. Enzymatic modifications
to histones control DNA activation or silencing through the addition or
removal of acetyl, methyl, and ubiquitin molecules in prescribed sequences
and patterns. One job of Ubp10, as identified in this study, is to remove
ubiquitin from certain histones where ubiquitin is associated with gene
activation and to maintain low levels of the ubiquitin molecule at those
sites.
Interestingly, Ubp10 appears
to work similarly and in concert with another enzyme called Sir2, which
removes acetyl molecules from histones. Sir2 has also been associated with
promoting genomic stability, and some studies have linked it intriguingly to
the aging process. Some studies, for example, have suggested that
low-calorie diets that extend life also boost Sir2 activity dramatically.
Source: The Wistar Institute |